Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary Bypass

Clinical trial NCT01478126 · COMPLETED

Trial details

NCT number: NCT01478126
Sponsor: Meshalkin Research Institute of Pathology of Circulation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Artery Disease

Start date: 2012-01-01
Primary completion: 2012-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.